Background Between people with and without inflammatory bowel disease (IBD), there was
no statistically significant difference in the probability of contracting the severe acute …

Background Patients with inflammatory bowel disease (IBD) may have a modified immune
response to SARS-CoV-2. The objectives were to evaluate the prevalence of COVID-19 in …

Background Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the
gastrointestinal tract. Crohn's disease (CD) and Ulcerative colitis (UC) are the two major …

Abstract Background In Italy, the incidence of SARS-CoV-2 infection peaked in April and
November 2020, defining two pandemic waves of coronavirus disease 2019 (COVID-19) …

Despite the impact of the Coronavirus Disease 2019 (COVID-19) pandemic, vaccine
hesitancy remains common in the general public and patients with Inflammatory Bowel …

(1) Scant information is available concerning the characteristics that may favour the
acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the …

The coronavirus disease (COVID-19) pandemic represents a global health challenge,
particularly considering concomitant diseases. Patients with inflammatory bowel diseases …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
lead to the development of the novel coronavirus disease (coronavirus disease 2019 …

When Coronavirus disease 2019 (COVID-19) vaccines became available, adults who were
on immunosuppressive medications were among the earlier groups recommended by the …

We have recently used Tofacitinib (TOFA) in a patient with severe ulcerative colitis (UC)
refractory to intensive intravenous steroid treatment (IIVT) and with concomitant SARS-CoV …